Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?

Management and Treatment of Hepatitis C: Are There Still Unsolved Problems and Unique Populations?

Direct-acting antivirals (DAA) have revolutionized the treatment of patients with chronic hepatitis C virus (HCV) infection, possibly leading to HCV elimination by 2030 as endorsed by the World Health Organization (WHO). However, some patients belonging to the so-called unique or special populations...

Full description

Bibliographic Details
Main Authors: Virginia Solitano, Maria Corina Plaz Torres, Nicola Pugliese, Alessio Aghemo
Format: Article
Language:English
Published: MDPI AG 2021-06-01
Series:Viruses
Subjects:
hepatitis C
unique populations
special populations
decompensated cirrhosis
chronic kidney disease
end stage renal disease
Online Access:https://www.mdpi.com/1999-4915/13/6/1048

Internet

https://www.mdpi.com/1999-4915/13/6/1048

Similar Items